Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta
Yong-Liang Xue, Hai-Xia Shi, Ferid Murad, Ka Bian, Yong-Liang Xue, Hai-Xia Shi, Ferid Murad, Ka Bian
Abstract
The vasodilatory effect of cinnamaldehyde was investigated for its mechanism of action using isolated rings of rat aorta. Cinnamaldehyde relaxed aortic rings precontracted with phenylephrine in a dose-dependent manner, was not affected by either the presence or removal of the endothelium. Pretreatment with NG-nitro-L-arginine methyl ester and 1H-[1,2,4]-oxadiazole-[4,3-a]-quinoxalin-1-one could not block vasodilation by cinnamaldehyde, indicating that nitric oxide signaling is not involved. Potassium channel blockers, such as glibenclamide, tetraethylammonium, and BaCl2, had no effect on the relaxation produced by cinnamaldehyde. In addition, treatment with either indomethacin or propranolol did not affect cinnamaldehyde-induced vasodilatation. On the other hand, pretreatment of endothelium-denuded rings with cinnamaldehyde significantly inhibited vasoconstriction induced by endogenous vasoconstrictors, including angiotensin II, 5-hydroxytryptamine, dopamine, endothelin-1, and phenylephrine. In a Ca2+-free experimental setting, this natural vasodilator not only blocked Ca2+ influx-dependent vasoconstriction by either phenylephrine or KCl, but also inhibited phenylephrine-induced tonic contraction, which relies on intracellular Ca2+ release. This study shows that endothelium-independent, Ca2+ influx and/or an inhibitory release mechanism contributes to the vasodilatory effect of cinnamaldehyde.
Keywords: cinnamaldehyde; endothelium; vascular smooth muscle cell; vasodilation.
Figures
References
- Teng Jia-lin T, Li Xing-Guang, Le Yin-Min. Chinese Materia Medica. Beijing, China: People’s Medical Publishing House; 2007. Chinese–English bilingual textbooks for international students of Chinese TCM institutions.
- Amin KA, Abd El-Twab TM. Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolemic rats: Role of atorvastatin and cinnamon. Int J Clin Exp Med. 2009;2(3):254–265.
- Panickar KS, Polansky MM, Anderson RA. Cinnamon polyphenols attenuate cell swelling and mitochondrial dysfunction following oxygen-glucose deprivation in glial cells. Exp Neurol. 2009;216(2):420–427.
- Kwon HK, Jeon WK, Hwang JS, et al. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8+ T cells. Cancer Lett. 2009;278(2):174–182.
- Peterson DW, George RC, Scaramozzino F, et al. Cinnamon extract inhibits tau aggregation associated with Alzheimer’s disease in vitro. J Alzheimers Dis. 2009;17(3):585–597.
- Wei RP, Huang YF, Hu DH, Zheng YG. Status and trends of researches on Cinnamomum cassia Presl. Nonwood Forest Research. 2006;24(3):65–70.
- Ma YY, Huo HR, Li CH, et al. Effects of cinnamaldehyde on PGE2 release and TRPV4 expression in mouse cerebral microvascular endothelial cells induced by interleukin-1β. Biol Pharm Bull. 2008;31(3):426–430.
- Chao LK, Hua KF, Hsu HY, et al. Cinnamaldehyde inhibits pro-inflammatory cytokine secretion from monocytes/macrophages through suppression of intracellular signaling. Food Chem Toxicol. 2008;46:220–231.
- Liao BC, Hsieh CW, Liu YC, Tzeng TT, Sun YW, Wung BS. Cinnamaldehyde inhibits the tumor necrosis factor-α-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-κB activation: Effects upon IκB and Nrf2. Toxicol Appl Pharmacol. 2008;292(2):161–171.
- Huang J, Wang S, Luo X, et al. Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents. Thromb Res. 2007;119(3):337–342.
- Takenaga M, Hirai A, Terano T, et al. In vitro effect of cinnamic aldehyde, a main component of Cinnamomi cortex, on human platelet aggregation and arachidonic acid metabolism. J Pharmacobiodyn. 1987;10(5):201–208.
- Xu Ming, Yu Lu, Ding Yuan-yuan, et al. Experimental study on hypotensive effects of cinnamaldehyde in anesthetized rats. Chin Heart J. 2006;28(3):272–276.
- Yanaga A, Goto H, Nakagawa T, et al. Cinnamaldehyde induces endothelium-dependent and -independent vasorelaxant action on isolated rat aorta. Biol Pharm Bull. 2006;29(12):2415–2418.
- Zhang Tuan-xiao, Niu Cai-qin, Jing Hua-e, et al. Effect of water decoction of the Gastrodia elata BI on vasodiIation of rabbit aorta in vitro. Journal of Clinical Rehabilitative Tissue Engineering Research. 2008;13(1):203988–203991.
- Bian K, Toda N. Reoxygenation and calcium-induced cerebroarterial contractions as affected by vasodilator agents. J Cereb Blood Flow Metab. 1988;8(6):808–815.
- Bian K, Doursout MF, Murad F. Vascular system: Role of nitric oxide in cardiovascular diseases. J Clin Hypertens (Greenwich) 2008;10(4):304–310.
- Bian K, Murad F. Nitric oxide (NO) – biogeneration, regulation, and relevance to human diseases. Front Biosci. 2003;8:d264–d278.
- Martin W, Villani GM, JotIlianandan D. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 1985;232(3):708–7l6.
- Jia Hong-jun, Wang Zhong-ling, Yang Qi-dong. Ion Channels and Cardio-Cerebrovascular Diseases Basic Science and Clinical Practice. Beijing, China: People’s Health Press; 2001.
- Bian K, Hermsmeyer K. Glyburide actions on the dihydropyridine-sensitive Ca2+ channel in rat vascular muscle. J Vasc Res. 1994;31(5):256–264.
- Liu ZX. Practical Cardiovascular Receptorology. Beijing, China: Science Press; 2001.
- Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: Dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4(7):517–529.
- Bian K, Hermsmeyer K. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries. Naunyn Schmiedebergs Arch Pharmacol. 1993;348(2):191–196.
- Yao T. Physiology. Beijing, China: People’s Health Press; 2003.
Source: PubMed